Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Hereditary angioedema medicine: Takeda Biopharma launches CINRYZE in India

Ruchika Sharma14 Dec 2022 12:06 PM IST

Hereditary Angioedema (HAE) is a rare genetic condition that causes swelling in different parts of the body like limbs, face, abdomen, and larynx .

Takeda to acquire Oral Allosteric TYK2 Inhibitor NDI-034858 from Nimbus Therapeutics

Ruchika Sharma14 Dec 2022 11:01 AM IST

Japan: Takeda has announced that it will acquire NDI-034858 from Nimbus Therapeutics. NDI-034858 is an oral, selective allosteric...

USFDA grants accelerated approval for Mirati Therapeutics lung cancer drug KRAZATI

Ruchika Sharma13 Dec 2022 3:30 PM IST

San Diego: Mirati Therapeutics, Inc., a targeted oncology company, has announced that the U.S. Food and Drug Administration (USFDA) has granted...

Hospitals cannot force patients to buy medicines from their affiliated stores: Maha FDA

Ruchika Sharma13 Dec 2022 2:30 PM IST

Pune: Patients cannot be compelled to purchase medicines from hospital-attached drug stores, the Maharashtra Food & Drug Administration (FDA) has...

Aspen Pharmacare gets USD 30 million grant to make vaccines

Ruchika Sharma13 Dec 2022 1:45 PM IST

Johannesburg: Aspen Pharmacare has wrapped up pacts to secure funding of $30 million from the Gates Foundation and the Coalition for Epidemic...

Pfizer eyes USD 10 billion- USD 15 billion in potential revenue from mRNA vaccines by 2030

Ruchika Sharma13 Dec 2022 12:13 PM IST

New York: Pfizer Inc said on Monday that annual revenue from its mRNA vaccine portfolio could reach $10 billion to $15 billion by 2030, alleviating...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck commences tender offer to purchase Imago BioSciences

Ruchika Sharma13 Dec 2022 11:15 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced that it has commenced through a subsidiary, a cash tender offer to...

Entod Pharma to launch GLO division for glaucoma

Ruchika Sharma12 Dec 2022 4:30 PM IST

New Delhi: Entod Pharmaceuticals has announced that the company is all set to launch its GLO division to further expand its business. This...

Roche Pharma CEO Bill Anderson to step down

Ruchika Sharma12 Dec 2022 3:30 PM IST

Anderson will be replaced on a temporary basis by Thomas Schinecker, the current head of diagnostics who is due to become group CEO on March 14.

Boston Scientific to purchase majority stake of Acotec Scientific Holdings

Ruchika Sharma12 Dec 2022 2:30 PM IST

The completion of the transaction, which is anticipated in the first half of 2023, is subject to acceptance and approval by Acotec shareholders and...

After Sanofi drops out of Horizon bid, Amgen emerges as frontrunner

Ruchika Sharma12 Dec 2022 1:30 PM IST

Sanofi said on Sunday that it was no longer in discussions with Horizon and does not intend to make an offer for it.

Include intranasal COVID vaccine iNCOVACC in CoWIN portal: Bharat Biotech urges Centre

Ruchika Sharma12 Dec 2022 12:30 PM IST

Currently, Bharat Biotech's Covaxin, Serum Institute's Covishield and Covovax, Russian Sputink V, and Biological E Ltd's Corbevax are listed in the...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok